The dopaminergic system subserves many aspects of normal human behavior and is involved in the pathogenesis of a number of psychiatric and neurological conditions, such as schizophrenia, drug abuse, and depression 
consist of the D1 and the D5 receptors, which are coupled to adenylate cyclase through G S .
The D2-like family of receptors are coupled through inhibitory G-proteins (thus mediating inhibitory neurotransmission) and have high affinities for a number of drugs with antipsychotic properties, although each receptor subtype has unique pharmacological features. For example, the D2 and D3 receptors have high affinity for raclopride, while the D4 receptor has a particularly high affinity for clozapine [8] . Interest in clozapine stems from its effectiveness in reducing positive and negative symptoms in acutely psychotic and treatment-resistant schizophrenic patients without eliciting extrapyramidal side effects [9] .
So far, the majority of studies addressing the localization of dopamine receptors (DR) in the human brain used dopamine receptor mRNA expression [10] [11] [12] or ligand binding [13] [14] [15] [16] [17] . These studies showed that the strongly expressed mRNA for dopamine receptors in PFC is DRD1 and DRD4 mRNA, other DR receptors being expressed in lower amount. Among the less abundantly expressed receptors, DRD2 has the strongest expression, and the DRD3 has the lowest expression.
In the primate PFC, the D2 dopamine receptors are localized in both pyramidal cells [18] and interneurons [19] [20] [21] . The strongest expression of DRD2 mRNA was found in the pyramidal cells of the layers II-III and V-VI [22, 23] .
The D4-receptor antibody labelled GABAergic neurons in many regions of the cerebral cortex, but also in a subset of cortical pyramidal cells [9] . However, the anatomical localization of DRD2 receptors and their possible function in astrocytes of PFC has not yet been examined.
The first report directly relating the effect of dopamine on astrocytes was by Henn and colleagues [24] , who documented the presence of large amount of haloperidolbinding sites on astrocyte membranes.
More recently, using immunohistochemical methods [20, 21, 25, 26] and RT-PCR [25] , D2-like receptors were found mainly in the interneurons, pyramidal neurons, and in astroglial processes. Measuring specific binding activity in isolated astrocytes from the cerebral cortex of human, monkey, rat, and mouse preparations, Khan and collaborators determined that approximately 35% of the total binding activity of the compounds with high affinities for D2-like receptors was associated with astrocytes [20] .
Considering the evidence that astrocytes may play an active role in neural communication [27] , in the present report we have focused on the expression of D2-like family of DR in two main astrocyte subclasses in normal human PFC using a panel of novel monoclonal antibodies [28] .
materials and methods

Tissue preparation
Tissue samples from the right orbitomedial Finally, peroxidase activity was visualized using Ni-3,3'-diaminobenzidine (DAB) (Sigma).
The specificity of the DRD2, DRD3, and DRD4 antibodies used has been previously characterized by Western blot analysis and immunocytochemistry [28] . The specificity was further confirmed in sections by obtaining no specific staining (negative controls) upon the use of preimmune serum or upon omission of the primary antibodies.
Immunohistochemistry for glial fibrillary acidic protein (GFAP) was performed using an anti-cow GFAP monoclonal rabbit IgG (Dako, Copenhagen, Denmark) in dilution 1:500, whereas expression of macrophage/microglial marker CD68 was revealed using a primary rat anti-mouse CD68 antibody (Serotec Ltd, Kidlington, Oxford, UK, cat. No. MCA1957) at 1:80 dilution.
results
The suggest an important modulatory role of dopamine on corticocortical connections [36] .
Also in contrast to rodents, dopaminergic afferents in monkey and human fetuses reach their prospective cortical targets as early as the first half of gestation, displaying the same regional and laminar distribution at birth as in adulthood, whereas in rodents some of dopamine afferents reach its cortical targets only after birth [37] . Our observation that the astrocytes in layer I and pyramidal and nonpyramidal neurons in the infragranular layers pattern similar to that of the DRD2 receptor, which is both unusual and unexpected, given its lack of cortical distribution in the rat [23] . In PFC regions, the mRNAs encoding the DRD1
and DRD4 receptors are the most abundant of the five receptor transcripts and can be observed in both infra-and supragranular layers [23] .
Our observation that the pyramidal and non-pyramidal cells of all three PFC regions analyzed had strong expression of DRD2 and DRD4 receptors, whereas DRD3 receptors were very weakly expressed is mostly in accordance with the known distribution of mRNA for dopamine receptors [9, 22, 23] . and striatal rat astrocytes [42] , whereas dopamine agonists increase the secretion of NGF and GDNF in cultured mouse astrocytes [43] . Furthermore, it has been shown that atypical neuroleptic drugs upregulate DRD2 expression in astrocyte cultures [44] . 
